The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Open accessAbstract
Elevated plasma clot lysis time (CLT) increases risk of venous and arterial thrombosis. It is unclear which fibrinolytic factors contribute to thrombosis risk. In 743 healthy control subjects we investigated determinants of CLT. By comparison with 770 thrombosis patients, we assessed plasma levels of fibrinolytic proteins as risk factors for a first thrombosis. Plasminogen activator inhibitor-1 (PAI-1) levels were the main determinants of CLT, followed by plasminogen, thrombin-activatable fibrinolysis inhibitor (TAFI), prothrombin, and α2-antiplasmin. Fibrinogen, factor VII, X, and XI contributed minimally. These proteins explained 77% of variation in CLT. Levels of the fibrinolytic factors were associated with thrombosis risk (odds ratios, highest quartile vs lowest, adjusted for age, sex, and body mass index: 1.6 for plasminogen, 1.2 for α2-antiplasmin, 1.6 for TAFI, 1.6 for PAI-1, and 1.8 for tissue plasminogen activator [t-PA]). Adjusting for acute-phase proteins attenuated the risk associated with elevated plasminogen levels. The risk associated with increased t-PA nearly disappeared after adjusting for acute-phase proteins and endothelial activation. TAFI and PAI-1 remained associated with thrombosis after extensive adjustment. In conclusion, CLT reflects levels of all fibrinolytic factors except t-PA. Plasminogen, TAFI, PAI-1, and t-PA are associated with venous thrombosis. However, plasminogen and t-PA levels may reflect underlying risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Hernan, M. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.2.176 · Cited by 1,445
Bajzar, L., Morser, J., & Nesheim, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16603 · Cited by 644
Juhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Pâques, E. P., Preissner, K. T., Müller-Berghaus, G., & Collen, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37610-0 · Cited by 485
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000) · Blood · doi:10.1182/blood.v95.9.2855.009k02_2855_2859 · Cited by 373
Self-citationLijnen, H. R., Hoylaerts, M., & Collen, D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70451-7 · Cited by 289
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
Lisman, T., de Groot, P. G., Meijers, J. C. M., & Rosendaal, F. R. (2005) · Blood · doi:10.1182/blood-2004-08-3253 · Cited by 282
Self-citation
Cited by
Fibrinolysis and the control of blood coagulation
Chapin, J. C., & Hajjar, K. A. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.09.003 · Cited by 839
Undas, A., & Ariëns, R. A. S. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230631 · Cited by 526
Cancer-associated pathways and biomarkers of venous thrombosis
Hisada, Y., & Mackman, N. (2017) · Blood · doi:10.1182/blood-2017-03-743211 · Cited by 443
Wolberg, A. S., Rosendaal, F. R., Weitz, J. I., Jaffer, I. H., Agnelli, G., Baglin, T., & Mackman, N. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.6 · Cited by 369
Self-citationProcoagulant Activity in Hemostasis and Thrombosis: Virchow's Triad Revisited
Wolberg, A. S., Aleman, M. M., Leiderman, K., & Machlus, K. R. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31823a088c · Cited by 312
Metadata
- Authors
- Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-07-08
- Volume
- 116
- Issue
- 1
- Pages
- 113-121
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2060836090
- Cited by
- 364
- References
- 31
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. https://app.cochat.ai/papers/10.1182/blood-2010-02-267740
- The paper
- Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010). Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood. https://doi.org/10.1182/blood-2010-02-267740
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.